Cargando…
Inhibition of Friend erythroleukaemia-cell tumours in vivo by a synthetic analogue of prostaglandin E2.
The effect of 16,16-dimethyl-PGE2-methyl ester (di-M-PGE2), a long-acting synthetic analogue of prostaglandin E2, on the replication of Friend erythroleukaemia cells (FLC) in vivo has been studied. Pre-treatment in vitro of both undifferentiated and differentiated FLC with di-M-PGE2 (1 microgram/ml)...
Autores principales: | Santoro, M. G., Jaffe, B. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009932/ https://www.ncbi.nlm.nih.gov/pubmed/286604 |
Ejemplares similares
-
Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.
por: Marini, S., et al.
Publicado: (1990) -
Effect of endogenous and exogenous prostaglandin E on Friend erythroleukaemia cell growth and differentiation.
por: Santoro, M. G., et al.
Publicado: (1979) -
BUDR inhibition of post-DMSO-induced erythroleukaemia cell differentiation in vitro.
por: Preisler, H. D.
Publicado: (1976) -
Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.
por: Bennett, A., et al.
Publicado: (1985) -
Observations on the “Eclipse Phase” in a Virus-associated Erythroleukaemia of the Chicken
por: Campbell, J. G.
Publicado: (1954)